A commentary on dose escalation and bNED in prostate cancer.
Kagan
A Robert
AR
Schulz
Robert J
RJ
D017326:Clinical Trials, Phase III as Topic; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000532:radiotherapy*; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D016896:Treatment Outcome
D017430:Prostate-Specific Antigen